Newsroom

The U.S. National Institutes of Health (NIH) today announced a $1.5 billion initiative to speed breakthroughs in diagnostic tests for the virus that causes COVID-19. The program aims to increase the U.S. capacity for SARS-CoV-2 testing up to 100-fold by late summer, in time for the start of the flu season.

Read more at Science.

The National Institutes of Health is launching a new initiative to turbocharge innovation, development and commercialization of COVID-19 testing technologies as a way to help society get back to a place where restrictions can be lifted.

Read more at Fox News.

A competition between researchers is part of a $1.5 billion program that seeks to speed development of accurate, quick and easy-to-use COVID-19 tests, NIH announced Wednesday.

Read HealthDay article at US News & World Report.

The National Institutes of Health on Wednesday announced a new $1.5 billion initiative to rapidly develop coronavirus diagnostics, an effort it says will result in the deployment of “millions of tests per week” by late summer or fall of this year.

Read more at STAT.

NIH has announced a new initiative aimed at speeding innovation, development and commercialization of COVID-19 testing technologies, a pivotal component needed to return to normal during this unprecedented global pandemic.

A team at ClearCam, Inc., with funding from the NIBIB and ties to the University of Texas at Austin, designed a device for wiping a laparoscope lens clean, much the same way that a wiper blade clears a fogged up window.

Marking a major milestone on the path to meeting the objectives of the NIH BRAIN initiative, researchers advance high-density electroencephalography (EEG) as the future paradigm for dynamic functional neuroimaging.

Medical physicists at the Mayo Clinic have just made a unique library of computed tomography (CT) data publicly available so that imaging researchers can study, develop, validate, and optimize algorithms and enhance imaging hardware to produce peak-quality CT images using low radiation doses.

In this interview, David Zierler, Oral Historian for AIP, interviews Richard Leapman, Senior Investigator in the National Institute for Biomedical Imaging and Bioengineering and Scientific Director of the intramural program. Leapman recounts his childhood in England and he describes his early and formative experience playing with an optical microscope. Source: American Institute of Physics